Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With Rheumatoid Arthritis (DOSERA)

The aim of this study is to analyze the changes in the "clinical and radiographic course in subjects when etanercept treatment is tapered or discontinued."

Study Type: Interventional

Age/Gender Requirement: 18 years+ (male/female)

Sponsor: Wyeth

The aim of this study is to analyze the changes in the "clinical and radiographic course in subjects when etanercept treatment is tapered or discontinued." The researchers will also evaluate "the subjects' experience of disease worsening and the predictive values of clinical parameters, serum biomarkers and imaging on the clinical and radiographic course in different treatment groups."

Click here to access this third-party website.

Related Videos
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Natalie McCormick, PhD | Credit: American College of Rheumatology
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Related Content
© 2023 MJH Life Sciences

All rights reserved.